Amikacin

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Amikacin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

NON-FDA APPROVED USES

  • Pneumonia, Hospital-Acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third-/fourth-generation cephalosporin)
  • Tuberculosis
  • Non-tubercular mycobacterial (NTM) infections
  • Nocardia
  • Aerosolized amikacin has been used for the management of cystic fibrosis exacerbations

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: January 30, 2017

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Amikacin ID - 540015 A1 - Dzintars,Kathryn,Pharm.D., BCPS AU - Pham,Paul,Pharm.D. Y1 - 2017/01/30/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540015/all/Amikacin PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -